Stock Events

Stock Events

ImpediMed 

$0.004000
2
-$0.00-25.93% Thursday 13:34

Statistics

Day High
0.004
Day Low
0.004
52W High
0.0409
52W Low
0.0033
Volume
19,916
Avg. Volume
27,595
Mkt Cap
8.15M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27AugExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.01
-0
-0
0
Expected EPS
-0.0009615673462999999
Actual EPS
-0.0057694040778

Financials

-182.54%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
8.13MRevenue
-14.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IPDQF. It's not an investment recommendation.
Cardano
3
ADA.CRYPTO
Ethereum
2
ETH.CRYPTO
Commonwealth Bank of Australia
2
CBA.AU
ANZ Group
2
ANZ.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers products and systems used to separate complex chemical and biological materials, similar to ImpediMed's bioimpedance spectroscopy solutions for fluid status monitoring.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the medical, industrial, and commercial sectors, offering products that compete in the diagnostics and research market alongside ImpediMed.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, overlapping with ImpediMed's market.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a broad range of medical devices, diagnostics, and nutritional products that compete with ImpediMed's solutions in the healthcare sector.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc specializes in medical technologies, services, and solutions, including diagnostic and monitoring devices that compete with ImpediMed's offerings.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with ImpediMed in the medical device sector.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is involved in the development, manufacture, and sale of medical devices, including surgical and patient monitoring products that compete with ImpediMed.
GE Aerospace
GE
Mkt Cap355.45B
General Electric Company, through its healthcare division, provides medical imaging, monitoring, biomanufacturing, and cell therapy technology, competing with ImpediMed in the medical diagnostics and monitoring space.
Koninklijke Philips N.V.
PHG
Mkt Cap26.12B
Koninklijke Philips N.V. offers health technology products and services in diagnostics, treatment, and connected care, with solutions that compete with ImpediMed's bioimpedance technology.

About

ImpediMed Limited is a medical technology firm that specializes in software solutions. The company is involved in the creation, production, and global distribution of sophisticated bioimpedance spectroscopy (BIS) equipment and its accompanying software applications, serving markets in Australia, North America, and beyond. Its principal offerings include: SOZO: A non-intrusive BIS device engineered for the evaluation of lymphedema and for tracking fluid levels in individuals afflicted with heart failure. SFB7: A single-channel, tetrapolar BIS instrument utilized to assess the body composition of healthy individuals. ImpediVET: Another single-channel, tetrapolar BIS device, tailored specifically for veterinary applications to measure fluid status and tissue characteristics in animals. ImpediMed primarily markets its advanced medical devices to healthcare institutions such as hospitals and clinics. The company was founded in 1999 and its headquarters are located in Pinkenba, Australia.
Show more...
CEO
Erik Anderson
Employees
77
Country
Australia
ISIN
AU000000IPD8
WKN
000A0M163

Listings

F
DE
R1J.F
AU
AU
IPD.AU
OTC Link
US
IPDQF

0 Comments

Share your thoughts

FAQ

What is ImpediMed stock price today?▼
The current price of IPDQF is $0.00 USD — it has decreased by -25.93% in the past 24 hours. Watch ImpediMed stock price performance more closely on the chart.
What is ImpediMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ImpediMed stocks are traded under the ticker IPDQF.
Is ImpediMed stock price growing?▼
IPDQF stock has fallen by -25.93% compared to the previous week, the month change is a +21.21% rise, over the last year ImpediMed has showed a -80% decrease.
What is ImpediMed market cap?▼
Today ImpediMed has the market capitalization of 8.15M
When is the next ImpediMed earnings date?▼
ImpediMed is going to release the next earnings report on February 25, 2027.
What were ImpediMed earnings last quarter?▼
IPDQF earnings for the last quarter are -0 USD per share, whereas the estimation was -0 USD resulting in a -500% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ImpediMed revenue for the last year?▼
ImpediMed revenue for the last year amounts to 8.13M USD.
What is ImpediMed net income for the last year?▼
IPDQF net income for the last year is -14.85M USD.
How many employees does ImpediMed have?▼
As of September 05, 2026, the company has 77 employees.
In which sector is ImpediMed located?▼
ImpediMed operates in the Health & Wellness sector.
When did ImpediMed complete a stock split?▼
ImpediMed has not had any recent stock splits.
Where is ImpediMed headquartered?▼
ImpediMed is headquartered in Eight Mile Plains, Australia.